COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension

Background Risk stratification plays an essential role in the management of patients with pulmonary arterial hypertension (PAH). The current European guidelines propose a three-stratum model to categorise risk as low, intermediate or high, based on the expected 1-year mortality. However, with this m... View More